News Focus
News Focus
Followers 2528
Posts 250766
Boards Moderated 33
Alias Born 05/06/2014

Re: mick post# 193387

Saturday, 01/12/2019 11:50:11 PM

Saturday, January 12, 2019 11:50:11 PM

Post# of 246420
$PMCB An Investigation of Enzymes Capable of Activating Cannabinoid Prodrugs PMCB

With the support from the studies reviewed in this chapter, this research aimed to isolate the phytocannabinoid cannabidiolic acid from Cannabis sativa plant material and to screen microbial cell lines which could potentially decarboxylate CBDA to CBD.

With the broad review of many different in vitro and in vivo studies citing the effects of CBD on various cancer cell lines, this natural product clearly could be the basis of a targeted cancer therapy. Cannabidiol is already an FDA-approved drug in other medicinal contexts and its high potential for other therapies could be harnessed if an appropriate manner of administration was developed. One approach involving Cell-in-aBox® begins with identifying a microbial cell line capable of enzymatic conversion of the inactive prodrug cannabidiolic acid to cannabidiol by performing cell assays on a variety of species from the literature discussed.

Ultimately, Cell-in-a-Box® technology could provide a potential mechanism of delivery for a genetically-engineered cell containing the gene necessary for an enzyme capable of catalyzing the conversion of
prodrug to active drug.

https://digscholarship.unco.edu/cgi/viewcontent.cgi?article=1128&context=theses&fbclid=IwAR0wiNSLbPjd8GucWMbR5fe42rr7G7iplI6bk4UJsIITYd_j_31w03ThJRo

investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today